Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03879525 · ClinicalTrials.gov registry record · NA
EMR Outcomes: Anxiety and Depression in Epilepsy
A NA study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT03879525 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 30 participants.
The verdict
NCT03879525, a NA study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
The purpose of this research is to find out how people with epilepsy and possible symptoms of anxiety or depression are doing for 6 months after a regular epilepsy clinic visit. Participants in this study will complete questionnaires either by phone or via the patient portal.
Interventions
- OTHER EMR-based-interventional method
- OTHER Telephone-based-standard method
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2019-12-16 |
| Est. Completion | 2021-09-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03879525
The ClinicalTrials.gov registry entry for NCT03879525 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which EMR-based-interventional method is the first listed.
NCT03879525 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03879525 about?
NCT03879525 is a clinical study titled "EMR Outcomes: Anxiety and Depression in Epilepsy". The purpose of this research is to find out how people with epilepsy and possible symptoms of anxiety or depression are doing for 6 months after a regular epilepsy clinic visit. Participants in this study will complete questionnaires either by phone or via the patient portal.
What is the current status of trial NCT03879525?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2019-12-16. Estimated completion is 2021-09-27.
What interventions are being tested in trial NCT03879525?
The interventions under investigation include: EMR-based-interventional method (OTHER), Telephone-based-standard method (OTHER).
Who is sponsoring clinical trial NCT03879525?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.